Gene Expression Responses to FUS, EWS, and TAF15 Reduction and Stress Granule Sequestration Analyses Identifies FET-Protein Non-Redundant Functions

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Blechingberg, Jenny ^a   Luo, Yonglun ^a   Bolund, Lars ^a   Damgaard, Christian Kroun ^a   Nielsen, Anders Lade ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FUSED IN SARCOMA PROTEIN; MESSENGER RNA; NUCLEIC ACID BINDING PROTEIN; PROTEIN FET; PROTEIN TAF15; RNA BINDING PROTEIN EWS; TATA BINDING PROTEIN ASSOCIATED FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL GRANULE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; EMBRYO; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; TRANSCRIPTION REGULATION;

BLOTTING, WESTERN; CELL LINE; CYTOPLASMIC GRANULES; HUMANS; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RNA-BINDING PROTEIN EWS; RNA-BINDING PROTEIN FUS; TATA-BINDING PROTEIN ASSOCIATED FACTORS;

EID: 84866671948     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046251     Document Type: Article

References (60)

1. Bertolotti A, Lutz Y, Heard DJ, Chambon P, Tora L, (1996) hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 15: 5022-5031.
2. Morohoshi F, Ootsuka Y, Arai K, Ichikawa H, Mitani S, et al. (1998) Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. Gene 221: 191-198.
3. Bertolotti A, Bell B, Tora L, (1999) The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Oncogene 18: 8000-8010.
4. Lerga A, Hallier M, Delva L, Orvain C, Gallais I, et al. (2001) Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem 276: 6807-6816.
5. Nguyen CD, Mansfield RE, Leung W, Vaz PM, Loughlin FE, et al. (2011) Characterization of a Family of RanBP2-Type Zinc Fingers that Can Recognize Single-Stranded RNA. J Mol Biol 407: 273-283.
6. Zinszner H, Sok J, Immanuel D, Yin Y, Ron D, (1997) TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 110 (Pt 15): 1741-1750.
7. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, et al. (1994) The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9: 3087-3097.
8. Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O, et al. (1998) EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol Cell Biol 18: 1489-1497.
9. Meissner M, Lopato S, Gotzmann J, Sauermann G, Barta A, (2003) Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins. Exp Cell Res 283: 184-195.
10. Zinszner H, Albalat R, Ron D, (1994) A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev 8: 2513-2526.
11. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, et al. (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240.
12. Shiohama A, Sasaki T, Noda S, Minoshima S, Shimizu N, (2007) Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. Exp Cell Res 313: 4196-4207.
13. Wang X, Arai S, Song X, Reichart D, Du K, et al. (2008) Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454: 126-130.
14. Andersson MK, Stahlberg A, Arvidsson Y, Olofsson A, Semb H, et al. (2008) The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol 9: 37.
15. Jobert L, Argentini M, Tora L, (2009) PRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function. Exp Cell Res 315: 1273-1286.
16. Belyanskaya LL, Gehrig PM, Gehring H, (2001) Exposure on cell surface and extensive arginine methylation of ewing sarcoma (EWS) protein. J Biol Chem 276: 18681-18687.
17. Gal J, Zhang J, Kwinter DM, Zhai J, Jia H, et al. (2011) Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging 32: e27-40.
18. Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, et al. (2010) ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29: 2841-2857.
19. Kanai Y, Dohmae N, Hirokawa N, (2004) Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43: 513-525.
20. Fujii R, Takumi T, (2005) TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J Cell Sci 118: 5755-5765.
21. Fujii R, Okabe S, Urushido T, Inoue K, Yoshimura A, et al. (2005) The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol 15: 587-593.
22. Blechingberg J, Holm IE, Nielsen AL, (2012) Characterization and expression analysis in the developing embryonic brain of the porcine FET family: FUS, EWS, and TAF15. Gene 493: 27-35.
23. Riggi N, Cironi L, Suva ML, Stamenkovic I, (2007) Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol 213: 4-20.
24. Tan AY, Manley JL, (2009) The TET family of proteins: functions and roles in disease. J Mol Cell Biol 1: 82-92.
25. Spitzer JI, Ugras S, Runge S, Decarolis P, Antonescu C, et al. (2011) mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma. Genes Chromosomes Cancer 50: 338-347.
26. Brooke GN, Culley RL, Dart DA, Mann DJ, Gaughan L, et al. (2011) FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth. Cancer Res 71: 914-924.
27. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323: 1208-1211.
28. Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, et al. (2011) Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet.
29. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205-1208.
30. Couthouis J, Hart MP, Erion R, King OD, Diaz Z, et al. (2012) Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet 21: 2899-2911.
31. Jellinger KA, (2009) Recent advances in our understanding of neurodegeneration. J Neural Transm 116: 1111-1162.
32. Sayre LM, Perry G, Smith MA, (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21: 172-188.
33. Anderson P, Kedersha N, (2009) Stress granules. Curr Biol 19: R397-398.
34. Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, et al. (2010) Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 19: 4160-4175.
35. Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, et al. (2010) FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67: 739-748.
36. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, et al. (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132: 2922-2931.
37. Neumann M, Bentmann E, Dormann D, Jawaid A, DeJesus-Hernandez M, et al. (2011) FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 134: 2595-2609.
38. Woulfe J, Gray DA, Mackenzie IR, (2010) FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol 20: 589-597.
39. Doi H, Okamura K, Bauer PO, Furukawa Y, Shimizu H, et al. (2008) RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells. J Biol Chem 283: 6489-6500.
40. Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y, (2010) The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci Res 66: 131-133.
41. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
42. Shaw G, Morse S, Ararat M, Graham FL, (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16: 869-871.
43. Anderson P, Kedersha N, (2006) RNA granules. J Cell Biol 172: 803-808.
44. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS, (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38: 3751-3757.
45. Thomsen R, Solvsten CA, Linnet TE, Blechingberg J, Nielsen AL, (2010) Analysis of qPCR data by converting exponentially related Ct values into linearly related X0 values. J Bioinform Comput Biol 8: 885-900.
46. Zhou Z, Thomsen R, Kahns S, Nielsen AL, (2010) The NSD3L histone methyltransferase regulates cell cycle and cell invasion in breast cancer cells. Biochem Biophys Res Commun 398: 565-570.
47. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
48. Suzuki R, Shimodaira H, (2006) Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22: 1540-1542.
49. Liu-Yesucevitz L, Bilgutay A, Zhang YJ, Vanderwyde T, Citro A, et al. (2010) Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One 5: e13250.
50. McDonald KK, Aulas A, Destroismaisons L, Pickles S, Beleac E, et al. (2011) TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum Mol Genet 20: 1400-1410.
51. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40: 572-574.
52. ALS online genetics database, King's College London, The Institute of Psychiatry website. Available: http://alsod.iop.kcl.ac.uk/Accessed 2012 Aug 31.
53. Lieber CS, (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77: 517-544.
54. Shahabi HN, Andersson DR, Nissbrandt H, (2008) Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production. Synapse 62: 379-388.
55. Shahabi HN, Westberg L, Melke J, Hakansson A, Belin AC, et al. (2009) Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population. J Neural Transm 116: 567-573.
56. Bell-Parikh LC, Guengerich FP, (1999) Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde. J Biol Chem 274: 23833-23840.
57. Weisskopf MG, Morozova N, O'Reilly EJ, McCullough ML, Calle EE, et al. (2009) Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 80: 558-561.
58. Wang H, O'Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, et al. (2011) Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol 68: 207-213.
59. Sanchez-Ramos C, Tierrez A, Fabregat-Andres O, Wild B, Sanchez-Cabo F, et al. (2011) PGC-1alpha regulates translocated in liposarcoma activity: role in oxidative stress gene expression. Antioxid Redox Signal 15: 325-337.
60. Hoell JI, Larsson E, Runge S, Nusbaum JD, Duggimpudi S, et al. (2011) RNA targets of wild-type and mutant FET family proteins. Nat Struct Mol Biol 18: 1428-1431.